tirzepatide gastric emptying 43 pounds down—and this is exactly how works 👇🏼✨ Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors to help: ✔️ Reduce appetite and cravings ✔️ Slow Liraglutide, semaglutide, and tirzepatide delay

Right from the formulation of the products to registration packaging designing printing and shipping everything is covered under our services in India and is done by our team experts

While GIP (Glucose-Dependent Insulinotropic Peptide) is associated with fat storage, insulin secretion, and bone health

GSTT1 null, GSTM1 null, and CAT minor allele genotypes were 21.7%, 33.3%, and 12.1%, respectively

Use the smallest insulin syringe that can hold your full dose volume

Versus placebo, tirzepatide was more efficacious in reducing body weight (-10.96Kg, -8.75Kg, and -6.16Kg for tirzepatide 15, 10, and 5mg respectively) than semaglutide (-5.24Kg, -4.44Kg, and -2.72Kg for semaglutide 2.0, 1.0, and 0.5mg respectively)